Managing outpatient asthma exacerbations

被引:4
作者
Roy, SR [1 ]
Milgrom, H [1 ]
机构
[1] Natl Jewish Med & Res Ctr, Dept Pediat, Denver, CO 80206 USA
关键词
D O I
10.1007/s11882-003-0032-7
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Asthma is a chronic inflammatory disease that renders individuals prone to acute exacerbations. Several allergic and nonallergic triggers can incite an asthma exacerbation. The goals of managing an asthma exacerbation are prompt recognition, rapid reversal of airflow obstruction, prevention of relapses, and forestalling future episodes. A written asthma home-management plan is essential to minimize the severity of exacerbations. Short-acting beta-agonists, oxygen, and corticosteroids are fundamental to early intervention in acute asthma exacerbation. Anticholinergics and magnesium sulfate can help nonresponders. Newer agents such as levalbuterol and long-acting beta-agonists might be future additions to our armamentarium of drugs to treat acute exacerbations. Initiation or intensification of long-term controller therapy, treatment of co-morbid conditions, and avoidance of possible triggers along with prompt follow-up can help prevent relapses. Listening to patient preferences and concerns to enhance adherence and regular follow-up care can help prevent future episodes.
引用
收藏
页码:179 / 189
页数:11
相关论文
共 52 条
[1]  
Ahrens R, 2001, J ALLERGY CLIN IMMUN, V108, P681
[2]   Modulation of T-cell function by R- and (S)-isomers of albuterol: Anti-inflammatory influences of (R)-isomers are negated in the presence of the (S)-isomer [J].
Baramki, D ;
Koester, J ;
Anderson, AJ ;
Borish, L .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 109 (03) :449-454
[3]   β-agonists:: What is the evidence that their use increases the risk of asthma morbidity and mortality? [J].
Beasley, R ;
Pearce, N ;
Crane, J ;
Burgess, C .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 104 (02) :S18-S30
[4]  
CATES CJ, 2002, COCHRANE DATABASE SY
[5]   Uncontrolled oxygen administration and respiratory failure in acute asthma [J].
Chien, JW ;
Ciufo, R ;
Novak, R ;
Skowronski, M ;
Nelson, J ;
Coreno, A ;
McFadden, ER .
CHEST, 2000, 117 (03) :728-733
[6]  
Closa RM, 1998, PEDIATR PULM, V26, P344, DOI 10.1002/(SICI)1099-0496(199811)26:5<344::AID-PPUL7>3.0.CO
[7]  
2-F
[8]   Tolerance to the bronchoprotective effect of β2-agonists:: Comparison of the enantiomers of salbutamol with racemic salbutamol and placebo [J].
Cockcroft, DW ;
Davis, BE ;
Swystun, VA ;
Marciniuk, DD .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 103 (06) :1049-1053
[9]  
EDMONDS ML, 2002, COCHRANE DATABASE SY
[10]   Prospective multicenter study of relapse following treatment for acute asthma among adults presenting to the emergency department [J].
Emerman, CL ;
Woodruff, PG ;
Cydulka, RK ;
Gibbs, MA ;
Pollack, CV ;
Camargo, CA .
CHEST, 1999, 115 (04) :919-927